ISET: Program to Test, Treat for PAD Reduces Amputations

Share this content:
ISET: Program to Test, Treat for PAD Reduces Amputations
ISET: Program to Test, Treat for PAD Reduces Amputations

(HealthDay News) -- Patients with peripheral arterial disease (PAD) who face amputation of a foot or leg can have their limb saved by minimally invasive surgery to improve blood flow, according to research presented Tuesday at the International Symposium on Endovascular Therapy, held from Jan. 31 to Feb. 4 in Hollywood, Fla.

Among the patients tested and treated in a limb salvage program, amputation rates dropped 79 percent, according to Julio Sanguily, M.D., a vascular surgeon with the Martin Health System in Stuart, Fla., who led the study. In the program, patients with PAD underwent an angiogram and, if needed, a procedure to clear out the blocked arteries and improve blood flow such as angioplasty or atherectomy, Sanguily explained. In addition, hyperbaric oxygen therapy was used.

In 2010, 24 of the 84 patients (29 percent) had amputations, and in 2011, only 12 percent of patients had amputations. In 2012, the percentage of patients who had amputations dropped to 4 percent. By 2013, it was only 2 percent, and in 2014 it was down to 1 percent, Sanguily told HealthDay.

According to Sanguily, the key to reducing amputations is first to educate doctors who treat those at highest risk -- such as elderly patients and those with diabetes or kidney failure -- about the improved treatments and have them refer patients to physicians who specialize in endovascular therapy. The procedure is covered by most health insurance plans, including Medicare, Sanguily added.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »